Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/bethesda-criteria-for-microsatellite-instability-testing-impact-on-the-kdUattYy0o
References (43)
-
MF Kane, M Loda, GM Gaida, J Lipman, R Mishra, H Goldman (1997)
Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell linesCancer Res, 57
-
J Balmaña, F Balaguer, S Castellví-Bel, EW Steyerberg, M Andreu, X Llor (2008)
Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patientsJ Med Genet, 45
-
V Piñol, A Castells, M Andreu, S Castellví-Bel, C Alenda, X Llor (2005)
Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancerJAMA, 293
-
MA Rodriguez-Bigas, CR Boland, SR Hamilton, DE Henson, JR Jass, PM Khan (1997)
A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelinesJ Natl Cancer Inst, 89
-
S Ferreira, I Claro, P Lage, B Filipe, R Fonseca, R Sousa (2008)
Colorectal adenomas in young patients: microsatellite instability is not a useful marker to detect new cases of Lynch syndromeDis Colon Rectum, 51
-
RA Barnetson, A Tenesa, SM Farrington, ID Nicholl, R Cetnarskyj, ME Porteous (2006)
Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancerN Engl J Med, 354
-
CR Boland, A Goel (2010)
Microsatellite instability in colorectal cancerGastroenterology, 138
-
LA Aaltonen, P Peltomäki, JP Mecklin, H Järvinen, JR Jass, JS Green (1994)
Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patientsCancer Res, 54
-
HT Lynch, A Chapelle (2003)
Hereditary colorectal cancerN Engl J Med, 348
-
E Holinski-Feder, Y Müller-Koch, W Friedl, G Moeslein, G Keller, J Plaschke (2001)
DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2J Biochem Biophys Meth, 47
-
A Gologan, A Krasinskas, J Hunt, DL Thull, L Farkas, AR Sepulveda (2005)
Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instabilityArch Pathol Lab Med, 129
-
HF Vasen, P Watson, JP Mecklin, HT Lynch (1999)
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCCGastroenterology, 116
-
M Nyström-Lahti, Y Wu, AL Moisio, RM Hofstra, J Osinga, JP Mecklin (1996)
DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancerHum Mol Genet, 5
-
L Pérez-Carbonell, C Ruiz-Ponte, C Guarinos, C Alenda, A Payá, A Brea (2011)
Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancerGut
-
C Tresallet, A Brouquet, C Julié, A Beauchet, C Vallot, F Ménégaux (2011)
Evaluation of predictive models in daily practice for the identification of patients with Lynch syndromeInt J Cancer doi
-
AK Rustgi (2007)
The genetics of hereditary colon cancerGenes Dev, 21
-
HF Vasen (2007)
Review article: the Lynch syndrome (hereditary nonpolyposis colorectal cancer)Aliment Pharmacol Ther, 26
-
LA Aaltonen, R Salovaara, P Kristo, F Canzian, A Hemminki, P Peltomäki (1998)
Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the diseaseN Engl J Med, 338
-
E Stoffel, B Mukherjee, VM Raymond, N Tayob, F Kastrinos, J Sparr (2009)
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndromeGastroenterology, 137
-
G Canard, JH Lefevre, C Colas, F Coulet, M Svrcek, O Lascols (2011)
Screening for Lynch syndrome in colorectal cancer: are we doing enough?Ann Surg Oncol
-
HF Vasen, JT Wijnen, FH Menko, JH Kleibeuker, BG Taal, G Griffioen (1996)
Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysisGastroenterology, 110
-
J Morrison, M Bronner, BH Leach, E Downs-Kelly, JR Goldblum, X Liu (2011)
Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approachScand J Gastroenterol, 46
-
SD Ramsey, L Clarke, R Etzioni, M Higashi, K Berry, N Urban (2001)
Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancerAnn Intern Med, 135
-
B Truta, YY Chen, AM Blanco, G Deng, PG Conrad, YH Kim (2008)
Tumor histology helps to identify Lynch syndrome among colorectal cancer patientsFam Cancer, 7
-
JR Jass (2004)
HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differencesFam Cancer, 3
-
CM Reyes, BA Allen, JP Terdiman, LS Wilson (2002)
Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectivenessCancer, 95
-
HJ Järvinen, M Aarnio, H Mustonen, K Aktan-Collan, LA Aaltonen, P Peltomäki (2000)
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancerGastroenterology, 118
-
P Peltomäki, H Vasen (2004)
Mutations associated with HNPCC predisposition—update of ICG-HNPCC/INSiGHT mutation databaseDis Markers, 20
-
Y Wu, MJ Berends, RG Mensink, C Kempinga, RH Sijmons, AG Zee (1999)
Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutationsAm J Hum Genet, 65
-
S Chen, W Wang, S Lee, K Nafa, J Lee, K Romans (2006)
Prediction of germline mutations and cancer risk in the Lynch syndromeJAMA, 296
-
YM Hendriks, A Wagner, H Morreau, F Menko, A Stormorken, F Quehenberger (2004)
Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillanceGastroenterology, 127
-
F Quehenberger, HF Vasen, HC Houwelingen (2005)
Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainmentJ Med Genet, 42
-
HF Vasen, JP Mecklin, PM Khan, HT Lynch (1991)
The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC)Dis Colon Rectum, 34
-
Y Wu, M Nyström-Lahti, J Osinga, MW Looman, P Peltomäki, LA Aaltonen (1997)
MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresisGenes Chromosomes Cancer, 18
-
F Rodríguez-Moranta, A Castells, M Andreu, V Piñol, S Castellví-Bel, C Alenda (2006)
Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendationsAm J Gastroenterol, 101
-
JP Terdiman, JR Gum, PG Conrad, GA Miller, V Weinberg, SC Crawley (2001)
Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testingGastroenterology, 120
-
E Jang, D Chung (2010)
Hereditary colon cancer: Lynch syndromeGut Liver, 4
-
A Umar, CR Boland, JP Terdiman, S Syngal, A Chapelle, J Rüschoff (2004)
Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instabilityJ Natl Cancer Inst, 96
-
KW Jasperson, TM Tuohy, DW Neklason, RW Burt (2010)
Hereditary and familial colon cancerGastroenterology, 138
-
C Julié, C Trésallet, A Brouquet, C Vallot, U Zimmermann, E Mitry (2008)
Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screeningAm J Gastroenterol, 103
-
AE Jong, M Puijenbroek, Y Hendriks, C Tops, J Wijnen, MG Ausems (2004)
Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancerClin Cancer Res, 10
-
H Hampel, WL Frankel, E Martin, M Arnold, K Khanduja, P Kuebler (2008)
Feasibility of screening for Lynch syndrome among patients with colorectal cancerJ Clin Oncol, 26
-
J Balmaña, DH Stockwell, EW Steyerberg, EM Stoffel, AM Deffenbaugh, JE Reid (2006)
Prediction of MLH1 and MSH2 mutations in Lynch syndromeJAMA, 296
- Publisher
- Springer Journals
- Copyright
- Copyright © 2012 by Springer Science+Business Media B.V.
- Subject
- Biomedicine; Biomedicine general; Epidemiology; Human Genetics; Cancer Research
- ISSN
- 1389-9600
- eISSN
- 1573-7292
- DOI
- 10.1007/s10689-012-9550-6
- pmid
- 22776989
- Publisher site
- See Article on Publisher Site
Abstract
In 1997 Bethesda Guidelines (BG) were established and in 2004 those criteria were revised (RBG), with the main goal of selecting colorectal cancers (CRC) that should be subjected to microsatellite instability (MSI) testing. High microsatellite instability (MSI-H) is an intermediate marker for mutational analysis of the mismatch repair (MMR) genes involved in the genesis of Lynch Syndrome (LS). We aimed to evaluate and compare BG/RBG in the detection of MSI-H and subsequent identification of pathogenic MMR genes mutations. We included 174 patients with CRC and indication for MSI analysis according to BG or RBG. MSI testing was performed with the Bethesda markers and mutational analysis of MLH1, MSH2 and MSH6 genes undertaken with DGGE, MLPA and direct sequencing. One hundred fourteen of 174 patients (65.5 %) fulfilled BG and all of them RBG. With the BG, MSI-H was detected in 37/114 (32.5 %) CRCs and mutational analysis was positive in 14/37 (37.8 %) patients. The RBG led to detection of MSI-H in 49/174 (28.2 %) of the CRCs, having the mutational analysis been positive in 16/49 (32.7 %) patients. We could identify 14/114 (12.3 %) new cases of LS, through BG and 16/174 (9.2 %) via RBG. BG presented a similar overall percentage for the detection of MSI-H and mutations when compared with RBG. RBG implicated the analysis of more patients, though they gave rise to detection of two additional LS cases. This difference has a significant impact on the establishment of preventive measures, mainly for CRC, in all the mutation-carriers belonging to these families.
Journal
Familial Cancer – Springer Journals
Published: Jul 10, 2012